Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.35
+0.26 (2.86%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lexeo Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$18.22
Upside
+94.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $19 | Buy | Initiates | $19 | +103.21% | Dec 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $19 | Buy | Initiates | $19 | +103.21% | Nov 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +81.82% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +39.04% | Oct 21, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +220.86% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $15 | Strong Buy | Maintains | $9 → $15 | +60.43% | Oct 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +81.82% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $9 → $20 | Buy | Maintains | $9 → $20 | +113.90% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $15 → $9 | Buy | Maintains | $15 → $9 | -3.74% | Aug 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +60.43% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $9 | Strong Buy | Maintains | $15 → $9 | -3.74% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $20 | Buy | Initiates | $20 | +113.90% | Jul 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $10 | Buy | Maintains | $16 → $10 | +6.95% | May 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $15 | Strong Buy | Maintains | $23 → $15 | +60.43% | May 16, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $22 → $20 | Strong Buy | Maintains | $22 → $20 | +113.90% | May 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +71.12% | May 12, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.